Year: 2025

On World AIDS Day 2025, Fluorobiotech joins the global community in remembering the lives lost to HIV/AIDS, honoring the resilience of those living with HIV, and reaffirming our commitment to a future in which prevention, diagnosis, and treatment are accessible, effective, and equitable for all. This year’s theme, “Ending the...

Fluorobiotech is proud to announce that we have officially been awarded ISO 13485 certification, a major achievement in our ongoing mission to enable high-quality, scalable biomanufacturing in Africa. A Global Standard in Quality and Compliance ISO 13485 is the internationally recognized standard for quality management systems specific to medical devices...

This week, Fluorobiotech’s COO, Ross Rayne Vermeulen, attended a landmark event in Johannesburg celebrating the launch of clinical trials for South Africa’s first domestically developed cholera vaccine, a major achievement led by Biovac. The ceremony marked the start of Phase I safety trials, representing a pivotal advancement not only for...

Last week, Fluorobiotech representatives Ross Rayne Vermeulen and Marthinus Janse van Vuuren attended the Africa Tech Festival, one of the continent’s leading gatherings for innovators, investors, policymakers, and technology developers. Their participation offered a timely opportunity to position biotechnology within the broader African innovation agenda and to highlight Fluorobiotech’s growing...

Last week, Fluorobiotech had the pleasure of welcoming representatives from the Medicines Patent Pool (MPP), Dr. Monica Moschioni (PhD, MPH) and Umut Demirtas to our laboratory at Stellenbosch University’s LaunchLab. Their visit formed part of ongoing efforts to strengthen partnerships that support Africa’s growing biotechnology and mRNA manufacturing ecosystems. We...

A landmark study presented at the 2025 European Society for Medical Oncology (ESMO) Congress by The University of Texas MD Anderson Cancer Center has provided compelling new evidence that mRNA technology may play a far greater therapeutic role than previously understood. While mRNA platforms gained global attention for their rapid...

Fluorobiotech is proud to share that the company and its co-founders, Dr. Du Preez van Staden and Dr. Ross Rayne Vermeulen, were recently profiled by the Stellenbosch Network as part of their prestigious Entrepreneur of the Month series. The feature highlights Fluorobiotech’s inspiring journey from academic research to biotechnology entrepreneurship,...

Fluorobiotech is proud to congratulate our Chief Quality Officer, Etienne du Toit, on the successful completion of the CQI and IRCA Certified Medical Devices – Quality Management Systems Auditor/Lead Auditor Training Course (ISO 13485:2016) (PR369). This prestigious certification highlights Etienne’s unwavering commitment to quality, compliance, and continuous improvement — values...

Fluorobiotech proudly joins the national celebration of National Science Week in South Africa - a time to reflect on the transformative role of science and technology in shaping a healthier, more sustainable future. As a biotechnology company rooted in innovation, Fluorobiotech recognizes that science is more than a discipline, it...